» Articles » PMID: 7579385

Tumor Necrosis Factor (TNF) is a Physiologic Regulator of Hematopoietic Progenitor Cells: Increase of Early Hematopoietic Progenitor Cells in TNF Receptor P55-deficient Mice in Vivo and Potent Inhibition of Progenitor Cell Proliferation by TNF Alpha...

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 1995 Oct 15
PMID 7579385
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Murine bone marrow cells with lineage phenotypes (Lin)-Sca-1+c-kit+ and Lin-Sca-1-c-kit+ cells represent primitive hematopoietic stem cells (HSCs) and committed hematopoietic progenitor cells, respectively. The number of Lin-Sca-1+c-kit+ HSCs in bone marrow was significantly increased in tumor necrosis factor (TNF) receptor p55-deficient (TNF-R55-1-) mice compared with the TNF-R55+/+ wild-type mice without a marked change in bone marrow cellularity. In both the methylcellulose culture and a single-cell proliferation assay, mouse TNF alpha (mTNF alpha) inhibited in vitro the proliferation of wild-type mouse-derived Lin-Sca-1+c-kit+ cells in response to a combination of multiple growth factors. The same is true for that of Lin-Sca-1+c-kit+ cells stimulated with granulocyte colony-stimulating factor (G-CSF) plus stem cell factor (SCF). Moreover, mTNF alpha significantly arrested the entry into S-phase from G0/G1 phase of Lin-Sca-1+c-kit+ cells stimulated with multiple growth factors and Lin-Sca-1-c-kit+ cells stimulated with G-CSF plus SCF. In contrast, mTNF alpha failed to affect the growth and cell cycle progression of Lin-Sca-1+c-kit+ cells and Lin-Sca-1-c-kit+ cells that were obtained from TNF-R55-deficient mice. These data suggest that TNF may be an important physiologic regulator of hematopoiesis and that TNF-R55 may be essentially involved in TNF-mediated inhibition of the growth of both primitive stem and more committed progenitor cells.

Citing Articles

Inflammation and Related Signaling Pathways in Acute Myeloid Leukemia.

Naji N, Sathish M, Karantanos T Cancers (Basel). 2024; 16(23).

PMID: 39682161 PMC: 11640130. DOI: 10.3390/cancers16233974.


Immunomodulatory and Anticancer Effects of Extract-Loaded Nanocapsules in Myeloid Leukemia.

de Freitas Gomes A, Batalha A, de Castro Alves C, Galvao de Azevedo R, Amado J, Pereira de Souza T Pharmaceutics. 2024; 16(6).

PMID: 38931948 PMC: 11207419. DOI: 10.3390/pharmaceutics16060828.


Knockouts of and Genes in K562 Cell Line Lead to Diverse Long-Lasting Responses to TNF-α.

Perik-Zavodskaia O, Alrhmoun S, Perik-Zavodskii R, Zhukova J, Lopatnikova J, Volynets M Int J Mol Sci. 2023; 24(24).

PMID: 38138998 PMC: 10742831. DOI: 10.3390/ijms242417169.


The Involvement of Macrophage Colony Stimulating Factor on Protein Hydrolysate Injection Mediated Hematopoietic Function Improvement.

Wang S, Zhang Y, Meng W, Dong Y, Zhang S, Teng L Cells. 2021; 10(10).

PMID: 34685756 PMC: 8534652. DOI: 10.3390/cells10102776.


B Cell Adhesion to Fibroblast-Like Synoviocytes Is Up-Regulated by Tumor Necrosis Factor-Alpha via Expression of Human Vascular Cell Adhesion Molecule-1 Mediated by B Cell-Activating Factor.

Yoon S, Moon E Int J Mol Sci. 2021; 22(13).

PMID: 34281218 PMC: 8267633. DOI: 10.3390/ijms22137166.